David Walsey, managing director and head of BrewLife's San Diego office, has moved to Alder BioPharmaceuticals as VP of corporate communications.
David Walsey |
Walsey was hired among a quartet of top executive hires at the Bothell, Wash.-based clinical stage pharma, which is advancing a migraine treatment into a key trial program.
Prior to Brewlife, part of W20 Group, Walsey led corporate communications for Sarpeta Therapeutics (then-AVI Biopharma), Arena Pharmaceuticals and Maxim Pharmaceuticals.
No comments have been submitted for this story yet.